ETS2 and neoplasm: Recent studies however suggest that ETS1 and ETS2 can also direct gene expression programs in opposite directions allowing these TFs to switch between oncogenic and tumor suppressive functions in cell-type specific manner [66]–whether similar mechanisms are at play in HNSCC begs further investigation.